ADVANCE INJECTABLES EXCELLENCE Trademark

Trademark Overview


On Thursday, May 3, 2018, a trademark application was filed for ADVANCE INJECTABLES EXCELLENCE with the United States Patent and Trademark Office. The USPTO has given the ADVANCE INJECTABLES EXCELLENCE trademark a serial number of 87905941. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 14, 2022. This trademark is owned by Sagent Pharmaceuticals, Inc.. The ADVANCE INJECTABLES EXCELLENCE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical injectable drugs for the treatment and prevention of cancer, cardiovascular disease, infections, pain, arthritis, psoriasis, diabetes, multiple sclerosis, anemia, hepatitis, hemophilia, osteoporosis, asthma, cystic fibrosis, pancreatitis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, systemic lupus erythematous, macular degeneration, migraines, growth hormone deficiency, chronic idiopathic urticaria, infertility, paroxysmal nocturnal hemoglobinuria, pneumonia, respiratory syncytial virus, varicella virus, human papillomavirus, and meningococcal disease
advance injectables excellence

General Information


Serial Number87905941
Word MarkADVANCE INJECTABLES EXCELLENCE
Filing DateThursday, May 3, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2019

Trademark Statements


Goods and ServicesPharmaceutical injectable drugs for the treatment and prevention of cancer, cardiovascular disease, infections, pain, arthritis, psoriasis, diabetes, multiple sclerosis, anemia, hepatitis, hemophilia, osteoporosis, asthma, cystic fibrosis, pancreatitis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, systemic lupus erythematous, macular degeneration, migraines, growth hormone deficiency, chronic idiopathic urticaria, infertility, paroxysmal nocturnal hemoglobinuria, pneumonia, respiratory syncytial virus, varicella virus, human papillomavirus, and meningococcal disease
Disclaimer with Predetermined Text"INJECTABLES"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 12, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSagent Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSchaumburg, IL 60195

Party NameSagent Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSchaumburg, IL 60195

Trademark Events


Event DateEvent Description
Monday, February 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, June 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 16, 2021EXTENSION 4 GRANTED
Wednesday, June 16, 2021EXTENSION 4 FILED
Wednesday, June 16, 2021TEAS EXTENSION RECEIVED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2020EXTENSION 3 GRANTED
Monday, December 14, 2020EXTENSION 3 FILED
Monday, December 14, 2020TEAS EXTENSION RECEIVED
Thursday, June 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 16, 2020EXTENSION 2 GRANTED
Tuesday, June 16, 2020EXTENSION 2 FILED
Tuesday, June 16, 2020TEAS EXTENSION RECEIVED
Friday, January 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 8, 2020EXTENSION 1 GRANTED
Wednesday, January 8, 2020EXTENSION 1 FILED
Wednesday, January 8, 2020TEAS EXTENSION RECEIVED
Tuesday, July 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 14, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 27, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 28, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 27, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 27, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 28, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 28, 2018NON-FINAL ACTION E-MAILED
Tuesday, August 28, 2018NON-FINAL ACTION WRITTEN
Saturday, August 25, 2018ASSIGNED TO EXAMINER
Saturday, May 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 7, 2018NEW APPLICATION ENTERED IN TRAM